Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 40 (3) , 239-246
- https://doi.org/10.1016/0166-4328(90)90080-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to ratsBehavioural Brain Research, 1989
- Modifications of the Serotonin System by Antidepressant TreatmentsJournal of Clinical Psychopharmacology, 1987
- The roles of monoaminergic neurotransmitters in thermoregulationCanadian Journal of Physiology and Pharmacology, 1987
- The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in catsBehavioural Brain Research, 1987
- Effects of Serotonin and Noradrenaline Uptake Blockers on Wakefulness and Sleep in CatsBasic & Clinical Pharmacology & Toxicology, 1987
- Similar effect on REM sleep but differential effect on slow wave sleep of the two 5-HT uptake inhibitors zimeldine and alaproclate in cats and ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- 5-HT-mediated behaviour Animal studiesNeuropharmacology, 1984
- An EEG averaging technique for automated sleep-wake stage identification in the ratPhysiology & Behavior, 1984
- Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analoguesNeuropharmacology, 1977